Ally Bridge Group as of Dec. 31, 2022
Portfolio Holdings for Ally Bridge Group
Ally Bridge Group holds 30 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ultragenyx Pharmaceutical (RARE) | 8.4 | $8.6M | 185k | 46.33 | |
| Aadi Bioscience (AADI) | 7.9 | $8.1M | 633k | 12.83 | |
| ACADIA Pharmaceuticals (ACAD) | 7.4 | $7.6M | 475k | 15.92 | |
| Mersana Therapeutics (MRSN) | 6.8 | $7.0M | 1.2M | 5.86 | |
| Galapagos Nv Spon Adr (GLPG) | 6.0 | $6.2M | 140k | 44.38 | |
| Allakos (ALLK) | 5.1 | $5.2M | 622k | 8.42 | |
| Seagen | 4.7 | $4.8M | 38k | 128.51 | |
| Atea Pharmaceuticals (AVIR) | 4.5 | $4.6M | 963k | 4.81 | |
| Sage Therapeutics (SAGE) | 4.4 | $4.5M | 119k | 38.14 | |
| Amarin Corp Spons Adr New (AMRN) | 4.4 | $4.5M | 3.7M | 1.21 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 3.9 | $4.0M | 326k | 12.39 | |
| Sana Biotechnology (SANA) | 3.9 | $4.0M | 1.0M | 3.95 | |
| Alkermes SHS (ALKS) | 3.6 | $3.7M | 142k | 26.13 | |
| Syros Pharmaceuticals Com New (SYRS) | 3.0 | $3.1M | 868k | 3.59 | |
| Karyopharm Therapeutics (KPTI) | 3.0 | $3.0M | 897k | 3.40 | |
| Nektar Therapeutics (NKTR) | 2.9 | $3.0M | 1.3M | 2.26 | |
| Selecta Biosciences (RNAC) | 2.8 | $2.9M | 2.6M | 1.13 | |
| Biohaven (BHVN) | 2.4 | $2.5M | 179k | 13.88 | |
| Rocket Pharmaceuticals (RCKT) | 2.4 | $2.4M | 125k | 19.57 | |
| Mirati Therapeutics | 2.1 | $2.2M | 48k | 45.31 | |
| Repligen Corporation (RGEN) | 2.0 | $2.1M | 12k | 169.31 | |
| Essa Pharma Com New (EPIX) | 2.0 | $2.0M | 812k | 2.52 | |
| Medavail Holdings Ord | 1.7 | $1.8M | 5.9M | 0.30 | |
| Praxis Precision Medicines I | 1.5 | $1.5M | 631k | 2.38 | |
| Morphosys Sponsored Ads (MOR) | 1.4 | $1.5M | 406k | 3.58 | |
| Rapid Micro Biosystems Class A Com (RPID) | 0.8 | $791k | 700k | 1.13 | |
| Curis Com New | 0.4 | $455k | 827k | 0.55 | |
| Nautilus Biotechnology (NAUT) | 0.3 | $287k | 159k | 1.80 | |
| Science 37 Holdings | 0.2 | $160k | 384k | 0.42 | |
| Denali Therapeutics (DNLI) | 0.1 | $125k | 4.5k | 27.81 |
